Nutriomics Logo Nutriomics Retina Logo
  • Home
  • Research
    • WP1 / Progression of obesity and related complications: role of gut microbiota?
    • WP2 / Intestine as a key player in metabolic disorders
    • WP3 / Adipose tissue Remodeling
    • WP4 / Systems’ biology and data integration (transversal WP)
    • WP5 / Translating our fundamental research for the benefit of patients
  • Team
    • Members
    • Workflow
    • History
  • Collabs
  • Cohorts
  • Tools
  • Publications
  • Contact
  • Home
  • Research
    • WP1 / Progression of obesity and related complications: role of gut microbiota?
    • WP2 / Intestine as a key player in metabolic disorders
    • WP3 / Adipose tissue Remodeling
    • WP4 / Systems’ biology and data integration (transversal WP)
    • WP5 / Translating our fundamental research for the benefit of patients
  • Team
    • Members
    • Workflow
    • History
  • Collabs
  • Cohorts
  • Tools
  • Publications
  • Contact
  • Nutrition and Obesities: Systemic Approaches

    Laboratory headed by Prof K. Clément.

    Our laboratory is conducting for many years basic and translational research in the area of obesity and related metabolic disorders.
  • Genetic determinants are strong contributors of early onset and severe obesity but in commoner forms, they are more considered a predisposing factor to obesity development in response to lifestyle changes (diet, physical inactivity, socio-economic factors).
  • In common obesity, we believe that phenomena related to molecular and structural maladaptation of the organism’s tissues as well as perturbations of the communication between these tissues contribute to the chronization, maintenance, and resistance to the weight loss treatment in this complex and heterogeneous disease.
  • Gut microbiota 3D view, bacteria
    Gut microbiota and intestine alterations are now considered as important actors of the pathophysiology of obesity and related disorders.
On-going work in the lab is focusing on
5 main topics
Nutriomics | Nutrition and Obesities: Systemic Approaches 2018-06-05T10:49:51+00:00

TOPIC 1

Progression of obesity and related complications: role of gut microbiota?

TOPIC 2

Intestine as a key player in metabolic disorders

TOPIC 3

Adipose tissue Remodeling

TOPIC 4

Systems’ biology and data integration (transversal WP)

TOPIC 5

Translating our fundamental research for the benefit of patients.

  • Define gut microbiota signature in CMD and evaluate the impact of environment (diet and drugs)
  • Demonstrate causality of CMD microbial signature in the development of CMD or its resolution:
    • in human interventions: Metacardis follow-up (development), diet or bariatric surgery (reversal)
    • in mice: gut microbiota transfer experiments (induce CMD or its reversal)

The intestine is a target for changes in external (food, microbiota) and internal (immune system) environment. Gut adaptation has in turn consequences on gut immunity, epithelial cells homeostasis and key organs for energy balance.

  • Understand WAT fibrosis : role of progenitors:
  • Characterize WAT senescence :
    • Evaluate inappropriate turnover of subcellular components (Lysosomal degradation)
    • Examine PG as gut-derived signaling modulators in AT remodeling

We will develop innovative tools for data analysis, physiological status prediction, and visualisation in metabolic diseases. Convergence of techniques include statistical inferences, machine learning, and mechanistic approach using dynamical systems. This WP is  strongly integrated with the other WPs which produce large-scale data.

Two main axes

  1. Develop innovative diagnosis and predictive factors/tools:
  2. Develop novel approaches for therapy with personalized medicine

Latest Publications

2018-09-18T15:36:25+00:00

Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance

August 18, 2018|Comments Off on Long-term Relapse of Type 2 Diabetes After Roux-en-Y Gastric Bypass: Prediction and Clinical Relevance

Diabetes Care 2018 Aug;
OBJECTIVE: Roux-en-Y gastric bypass (RYGB) induces type 2 diabetes remission (DR) in 60% of patients at 1 year, yet long-term rela...

2018-09-18T15:37:05+00:00

Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes

July 18, 2018|Comments Off on Increased jejunal permeability in human obesity is revealed by a lipid challenge and is linked to inflammation and type 2 diabetes

J. Pathol. 2018 Jul;
Obesity and its metabolic complications are characterized by subclinical systemic and tissue inflammation. In rodent models of obesity, inflammatio...

2018-03-08T11:10:17+00:00

Gut microbiota and obesity: Concepts relevant to clinical care

March 8, 2018|Comments Off on Gut microbiota and obesity: Concepts relevant to clinical care

Eur. J. Intern. Med. 2018 Feb;48:18-24
The composition and function of gut microbiota play a role in obesity and metabolic disease, yet the mechanisms have not been fully described. As n...

2017-10-05T23:41:09+00:00

The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass

July 22, 2017|Comments Off on The advanced-DiaRem score improves prediction of diabetes remission 1 year post-Roux-en-Y gastric bypass

Diabetologia 2017 Jul;
AIMS/HYPOTHESIS: Not all people with type 2 diabetes who undergo bariatric surgery achieve diabetes remission. Thus it is critical...

2017-10-05T23:40:36+00:00

Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue

June 8, 2017|Comments Off on Immune cell-derived cytokines contribute to obesity-related inflammation, fibrogenesis and metabolic deregulation in human adipose tissue

Sci Rep 2017 Jun;7(1):3000
Adipose tissue contains a variety of immune cells, which vary in abundance and phenotype with obesity. The contribution of immune cell-derived fact...

2017-10-05T23:41:12+00:00

The FAT Score, a Fibrosis Score of Adipose Tissue: Predicting Weight-Loss Outcome After Gastric Bypass

April 18, 2017|Comments Off on The FAT Score, a Fibrosis Score of Adipose Tissue: Predicting Weight-Loss Outcome After Gastric Bypass

J. Clin. Endocrinol. Metab. 2017 Jul;102(7):2443-2453
Context: Bariatric surgery (BS) induces major and sustainable weight loss in many patients. Factors predicting poor weight-loss re...

2017-10-05T23:40:58+00:00

Prospective assessment and histological analysis of adherent perinephric fat in partial nephrectomies

March 25, 2017|Comments Off on Prospective assessment and histological analysis of adherent perinephric fat in partial nephrectomies

Urol. Oncol. 2017 Feb;35(2):39.e9-39.e17
OBJECTIVES: The complexity of partial nephrectomy (PN) is partly anticipated by morphometric tumor-based scores that do not consid...

2017-10-05T23:40:41+00:00

Knee and hip intra-articular adipose tissues (IAATs) compared with autologous subcutaneous adipose tissue: a specific phenotype for a central player in osteoarthritis

March 16, 2017|Comments Off on Knee and hip intra-articular adipose tissues (IAATs) compared with autologous subcutaneous adipose tissue: a specific phenotype for a central player in osteoarthritis

Ann. Rheum. Dis. 2017 Jun;76(6):1142-1148
OBJECTIVES: Compared with subcutaneous adipose tissue (SCAT), infrapatellar fat pad (IFP), the main knee intra-articular adipose t...

  • Logo ICAN Institute of Cardiometabolism And Nutrition
  • logo Inserm - Institut national de la santé et de la recherche médicale
  • Logo UPMC Université Pierre et Marie Curie
  • Logo APHP Assistance Publique Hôpitaux de Paris
  • Home
  • Research
  • Team
  • Publications
  • Cohorts
  • Tools
  • Contact & Plan
Copyright 2012 - 2017 Nutriomics | All Rights Reserved